Cerebras officer plans $10.2M stock sale
Rhea-AI Filing Summary
Cerebras Systems Inc. (CBRS) received a Rule 144 notice from officer Sean Lie covering the proposed sale of 53,460 shares of common stock, consisting of 7,319 shares from Performance Stock Units vesting on June 5, 2026 and 46,141 shares from stock option exercises on September 4, 2026, through Morgan Stanley Smith Barney LLC.
The filing also lists prior sales of Cerebras common stock during the three months before this notice by Sean Lie and related entities, including several large transactions executed under Rule 10b5‑1 trading plans.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 53,460 shares
Aggregate market value of proposed sale: $10,180,922.40
Performance Stock Units shares: 7,319 shares
+5 more
8 metrics
Shares proposed to be sold
53,460 shares
Cerebras common stock covered by the Rule 144 notice
Aggregate market value of proposed sale
$10,180,922.40
Value associated with 53,460 shares of Cerebras common stock
Performance Stock Units shares
7,319 shares
Common stock from Performance Stock Units dated June 5, 2026
Option exercise shares
46,141 shares
Common stock from exercise of stock options dated September 4, 2026
Largest recent sale by Sean Lie
710,247 shares for $147,629,203.38
Sale of Cerebras common stock on August 20, 2026
Recent sale on August 21, 2026 (Grounded Love Fund)
213,074 shares for $42,428,338.94
Cerebras common stock sold during prior three months
Recent sale on August 21, 2026 (10b5‑1 for Sean Lie)
16,293 shares for $3,421,670.12
Cerebras common stock sold under a 10b5‑1 designation
Recent sale on August 18, 2026
21,257 shares for $4,720,625.00
Cerebras common stock sale listed in past three months
Key Terms
Rule 144, Performance Stock Units, Exercise of Stock Options, 10b5-1, +1 more
5 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Performance Stock Units financial
"Common | 06/05/2026 | Performance Stock Units | Issuer"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
Exercise of Stock Options financial
"Common | 09/04/2026 | Exercise of Stock Options | Issuer"
10b5-1 regulatory
"10b5-1 Sales for SEAN LIE 1237 E. Arques Avenue"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
FAQ
What does the Form 144 filing by Sean Lie mean for Cerebras Systems (CBRS)?
The Form 144 reports that officer Sean Lie plans to resell 53,460 shares of Cerebras Systems common stock under Rule 144. It is a notice of a potential resale of already-issued shares and does not itself involve new share issuance by the company.
What Cerebras (CBRS) stock sales has Sean Lie reported in the past three months?
The filing lists several sales, including 710,247 shares on August 20, 2026 for $147,629,203.38 and 213,074 shares on August 21, 2026 for $42,428,338.94, among other smaller transactions, some executed under Rule 10b5‑1 plans.
AI-generated analysis. How Rhea-AI works. Not financial advice.